Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer

CONCLUSIONS: In patients with PDAC, detection of KRAS mutations in plasma proved independently predictive of early recurrence after surgical resection but did not correlate with PFS following chemotherapy.PMID:34632919 | DOI:10.1080/15384047.2021.1980312
Source: Cancer Biology and Therapy - Category: Cancer & Oncology Authors: Source Type: research